Search

The article discusses the good manufacturing practice (GMP) compliance data of Japanese manufacturers that are being entered into the EudraGMDP database, an initiative between the Japanese Ministry of Health, Labour and Welfar (MHLW) and the European Medicines Agency's (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) which aims to speed up regulatory procedures and save time for importers, manufacturers and regulatory authorities. It references the EMA Press Release on October 7, 2013.

The article discusses the European Medicines Agency's (EMA) version of the European Clinical Trials Database, EudraCT V9, marking the first step of a process through which summary clinical trial results will be available to the public through the EU Clinical Trials Register (EU CTR).